The importance of plasma and extracellular fluid volumes in the mechanism of the antihypertensive effect of chlorothiazide is disputed. The present investigation indicates that the lowering of blood pressure is accompanied by reductions in plasma and extracellular fluid volumes and in body weight. Furthermore, re-expansion of plasma volume with salt-free dextran reverses the antihypertensive effect. However, since gradual reaccumulation of extracellular fluid occurs during 1 year of continuous treatment, the late antihypertensive effects of chlorothiazide cannot be explained by the volume-depletion mechanism.
T HE discovery of the antihypertensive action of chlorothiazide" 2 raised certain questions as to its mechanism of action. These questions included (1) whether the hypotensive response was caused by salt depletion or by some independent factor; (2) if produced by salt loss, by what mechanism it reduced blood pressure; (3) the factors that lead to increased reactivity to other antihypertensive agents; and (4) the reason for the moderate antihypertensive action of the drug when used alone in hypertensive patients and the absence of such activity in normotensive subjects.3 4 Complete answers to these questions cannot yet be given. This report concerns an attempt to elucidate some of the factors involved.
MATERIALS AND METHODS
Twenty male hypertensive patients with no symptoms or signs of congestive heart failure or edema were hospitalized and placed on a standard diet containing 1.5 Gm. of salt per day plus a supplement of 3 Gm. of salt in tablet form. This supplied a sodium intake of approximately 75 mEq. per day. Most of these patients were under treatment with other antihypertensive agents (table 1), which were continued during the entice period of study. A 4-day period for acclimatization to the diet was instituted in order to obtair stabilization of body weight and electrolyte excretions as well as average basal blood pressure readings. Determinations of plasma and extracellular volumes, serum electrolyte concentrations, and serum bicarbonate were carried out on the morning of the fifth day. Each patient was then given 500 rng. of chlorothiazide twice daily, and the studies were repeated after a period of 3 to 8 (average 6) days.
In 11 patients carefully screened for reliability and conscientiousness in regard to taking their medications, studies were repeated at approximuately 6 -month intervals for a period of 12 months. Seven of these patients were hospitalized and placed on the controlled salt intake for 2 to 3 days prior to repeating the determinations, while the remaining 4 were hospitalized for 1 daye only because of their inability to take time out from work. Thus, dietary intake of salt cannot be regarded as well controlled in the long-termn studies. At approximately 6 months following initiation of treatment the determinations of plasma and extracellular volumes in 7 patients were repeated. Chlorothiazide therapy was then discontiued for 1 week, after which another series of determinations were carried out. The patients remained hospitalized throughout this latter period.
PLUID VOLUME DEPLETION iO2J The effect of restoration of the plasma volume was determined in 7 patients who exhibited significant hypotensive responses to chlorothiazide. Each patient received 500 ml. of 6 per cent dextran in normal saline; and after several days the procedure was repeated with substitution of a similar volume of dextran in a per cent glucose in water. The infusion rate was approximately 25 ml. per minute. Blood pressure and heart rate were determined repeatedly before and throughout the procedure and blood for hematoerit determinations was drawn immediately preceding and following each infusion.
RESULTS

Acute Effects of Chlorothiazide
Following 3 to 8 (mean 6) days of chlorothiazide therapy the plasma volume showed some reduction in all of 20 nonedematous hypertensive patients ( J.We. Since the plasma volume is in equilibrium with the interstitial fluids, it also shared in the general reduction of extracellular fluid space. However, the relationship between change in extracellular and plasma volumes is only approximate.'. Because of the failure to find any evidence for significant cellular losses of sodium, the question arose whether the antihypertensive effect was related simply to the decrease in total circulating blood volume and to a reduction in tissue pressure secondary to the extracellular fluid loss. Such an interpretation is supported by the observation of Crosley and his associates14 that right heart pressures and cardiac output are reduced by chlorothiazide. Preliminary results in this laboratory tend to confirm these observations. Dustan and her co-workers'5 also found a reduction in cardiac output following chlorothiazide. If the antihypertensive effects of chlorothiazide were due to a change in intracellular sodium concentration producing a decrease either in arteriolar tone or a dehydration of "waterlogged" arterioles,16 the hemodynamic effects should be reflected in a reduction of total peripheral resistance rather than a fall in cardiac filling pressures and output. The latter findings, however, are readily explained by the decreases in plasma and extracellular fluid volumes. It is of interest that the normotensive individual compensates so that the basal blood pressure is not lowered, whereas this compensation seems to be deficient in hypertensive patients. 3 4 Whether such failure of homeostasis is due to a decreased responsiveness of the baroreceptors or to other factors cannot be determined on the basis of present evidence.
The importance of the plasma volume change in the mechanism of the antihypertensive effect was indicated by the fact that restoration of plasma volume either with or without any replenishment of sodium restored the blood pressure to essentially pretreatneiit levels. The lack of a quantitative relationship between the decrease in plasma volume and the fall of blood pressure can be explained on the basis of variations ill the activity of compensatory mechanisms ini-('hiding the baroreceptor reflexes, and initrinsic vascular distensibility inl different individuals. This variability was further enhanced by the fact that some of the patients were taking ganglion-blocking drugs and others were not.
These conclusions on the importance of oligemia in the mechanism of the antihypertensive action of chlorothiazide confirm ou. initial findings3 and are similar to those expressed by Dustan, Tapia, and associates.15 ' 17 They propose that the oligemia enhances vasomotor "tone" which in turn makes the patient more responsive to ganglion-blocking agents. However, the observation that the hypertensive patient often shows some reduction of blood pressure with chlorothiazide alone whereas the normotensive subject does not3 4 suggests that the compensatory mechanisms for plasma volume depletion often are inadequate in hypertension. Also, the decreased responsiveness to norepinephrine following chlorothiazide 18 19 in normotensive subjects is not readily explained on the basis of increased vasomotor tone alone, and suggests that reactivity is dependent to some extent on the degree of filling of the vascular system.
The failure to observe a significant reduction of plasma volume after 6 to 12 months of treatment reflects either tolerance to the saluretic effects of the drug or the establishment of compensatory mechanisms for restoration of homeostasis. Compensatory mechanisms become active after the first 48 hours of treatment when the output of sodium comes back into balance with the intake.
However, in the first month of treatment the depletion achieved during the initial saluresis is maintained and only gradually, thereafter, is the plasma volume deficit made up.
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